The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System.
Saved in:
| Title: | The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System. |
|---|---|
| Authors: | Alsuhaibani DS; Pharmaceutical Care Department, Medical Services for Armed Forces, Ministry of Defense, Riyadh, Saudi Arabia., Edrees HH; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA., Alshammari TM; Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.; College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia. |
| Source: | Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2023 Jul; Vol. 31 (7), pp. 1360-1366. Date of Electronic Publication: 2023 Jun 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer in collaboration with King Saud University Country of Publication: Netherlands NLM ID: 9705695 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1319-0164 (Print) Linking ISSN: 13190164 NLM ISO Abbreviation: Saudi Pharm J Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1319-0164 |
|---|---|
| DOI: | 10.1016/j.jsps.2023.05.023 |
